Skip to main content
OpenTrials

Clinical trial condition

Urogenital Diseases

Explore clinical trials studying Urogenital Diseases. Study availability and eligibility vary by location and protocol.

40,124 public trials 6,115 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Diseases trial results

Recruiting

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT07005154

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Sharp HealthCare - Sharp Memorial Hospital San Diego, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Associated Urological Specialists Chicago Ridge, Illinois, United States
View all 54 locations
View Trial Details
Recruiting

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

NCT07545811

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Prisma Health Cancer Institute Greenville, South Carolina, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • SCRI at Mary Crowley Dallas, Texas, United States
View Trial Details
Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

NCT05950464

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

NCT07755436

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • NEXT Oncology Irving, Texas, United States
  • NEXT Oncology Fairfax, Virginia, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions